Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of harmful effects in non-randomised studiesMethylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescentsImmediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adultsPsychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gapMultimodal MR imaging of brain iron in attention deficit hyperactivity disorder: a noninvasive biomarker that responds to psychostimulant treatment?The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial.Does Methylphenidate Affect Cystometric Parameters in Spontaneously Hypertensive Rats?Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorderAdolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate.A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.A dual physiological character for cerebral mechanisms of sexuality and cognition: common somatic peripheral afferents.Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag).The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.Restless legs syndrome as a possible predictor for psychiatric disorders in parents of children with ADHD.Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.Unraveling Individual Differences In The HIV-1 Transgenic Rat: Therapeutic Efficacy Of Methylphenidate.ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.Effectiveness of atomoxetine and methylphenidate for problematic online gaming in adolescents with attention deficit hyperactivity disorder.The effects of methylphenidate on whole brain intrinsic functional connectivity.Determination of monoamine neurotransmitters in zebrafish (Danio rerio) by gas chromatography coupled to mass spectrometry with a two-step derivatization.Common alterations in sensitivity to type but not amount of reward in ADHD and autism spectrum disorders.Impaired cliff avoidance reaction in dopamine transporter knockout mice.Executive impairment determines ADHD medication response: implications for academic achievement.
P2860
Q22061981-BFF6865A-1FC8-414F-8D2E-1250800C4CC2Q24186221-C9DD1234-3E8A-40DE-BB93-F1103CC4AB19Q24198192-CE48AC49-6FE8-46D9-A61E-2AF97A0D5C65Q26471999-DAAF7C1F-A60B-456F-B5C2-8AEC33057527Q28081111-C21810E1-5EEF-4F65-A5DB-2CFF47B99587Q30831762-9E819C24-AC29-4806-B32A-43A5C701AB75Q34233624-E8CB66B1-EB72-4A96-9D1A-E1F4C455E4A9Q35813297-14A6B891-B2D2-4E19-88B6-4FF6EEDB7545Q36751226-9C924710-71F7-4E9B-B8D6-C36F44FF1DB8Q37005445-7840EE6B-0739-479D-8204-DBD6DC480296Q37118184-E3BB866B-7DFC-41A8-9D01-9ADC6CA83AFEQ37143837-D60A78F6-D94E-4089-9199-85FD76B6E942Q37724221-46AE7002-6313-4E4F-8383-EBBC10EFCB57Q38239633-87111B31-B020-4450-B1CB-A4F1F9120E5CQ39761066-DDE8DEFA-BE85-4F70-B26F-3A48DABB0971Q43132071-D5F7336A-8E85-45EA-AF37-F76ECE12B546Q43889522-F17C87F3-030E-470D-B47F-15B5D4F8A733Q45226475-F6382BF0-EC96-4300-BE99-6F2FAC9C5139Q47150280-FF0A3B0B-65E7-4228-84DD-A6A89A762737Q47873338-44D1F514-8390-411C-A9F5-BBBAC2B4117BQ48010284-AE09178A-2FAF-49D9-AC85-A808182E8366Q48032360-2769A25F-6340-41A7-9D8D-1F35459EFBF9Q48287168-85C99E18-BFBF-404E-BD0D-0BC776844011Q48306566-49A03CB2-81B8-4CB1-B042-CAA2A9EA0168Q49076522-C468A333-27F9-4FD1-9DCA-1546F76A5DF6Q50056818-8D420DC2-D014-40D0-A8D0-ADC05ED96D55Q51017656-738F36D8-0B61-4DFB-9B6E-48CB6C585062
P2860
Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@ast
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@en
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@nl
type
label
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@ast
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@en
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@nl
prefLabel
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@ast
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@en
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@nl
P2860
P1476
Dopaminergic and noradrenergic ...... D: the role of methylphenidate
@en
P2860
P304
P356
10.2174/157015908787386069
P577
2008-12-01T00:00:00Z